JANUVIA (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the JANUVIA drug offered from Merck Sharp & Dohme Corp.. This Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
| NON-PROPRIETARY NAME: | sitagliptin |
| SUBSTANCE NAME: | SITAGLIPTIN PHOSPHATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2006-10-16 |
| END MARKETING DATE: | 0000-00-00 |
JANUVIA HUMAN PRESCRIPTION DRUG Details:
| Item Description | JANUVIA from Merck Sharp & Dohme Corp. |
| LABELER NAME: | Merck Sharp & Dohme Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/1) |
| START MARKETING DATE: | 2006-10-16 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0006-0112_f9f3a9af-477e-4325-a8d6-ce8d675c9e9b |
| PRODUCT NDC: | 0006-0112 |
| APPLICATION NUMBER: | NDA021995 |
Other SITAGLIPTIN PHOSPHATE Pharmaceutical Manufacturers / Labelers:
